The mechanistic link between obesity-related cognitive decline and gut health has been elusive, but this multi-cohort investigation reveals how specific bacterial populations directly influence brain attention networks through tryptophan metabolism. The finding could reshape therapeutic approaches for cognitive impairment in metabolic disorders.
Analyzing over 1,000 participants across three independent cohorts, researchers identified that obesity consistently impairs attention while altering gut bacterial composition. Proteobacteria species emerged as key culprits, disrupting tryptophan biosynthesis pathways and reducing production of 3-hydroxyanthranilic acid (3-HAA), a metabolite that correlates positively with attention performance. Conversely, anthranilic acid accumulation showed negative associations with cognitive function. Bariatric surgery patients demonstrated attention improvements alongside restoration of beneficial bacterial populations.
Faecal microbiota transplantation experiments in mice confirmed causality: transferring microbiomes from attention-impaired donors reduced 3-HAA and serotonin metabolite concentrations in the prefrontal cortex, while healthy donor microbiomes restored these neurotransmitter precursors. The research establishes a direct gut-brain axis where bacterial tryptophan processing influences dopaminergic signaling pathways critical for sustained attention.
This represents a paradigm shift from viewing obesity-related cognitive decline as purely metabolic toward understanding it as a microbiome-mediated neurochemical disruption. The identification of 3-HAA as a key mediator suggests targeted probiotic interventions could potentially restore attention function independent of weight loss. However, the complexity of individual microbiome variations and the preliminary nature of therapeutic applications warrant cautious interpretation pending clinical validation studies.